Anti-RAS antibodies show poor reliability in recognizing RAS proteins

October 5, 2017 by Will Sansom, University of Texas Health Science Center at San Antonio
Credit: University of Texas Health Science Center at San Antonio

Researchers from the Greehey Children's Cancer Research Institute at UT Health San Antonio co-authored a paper published Sept. 26 in Science Signaling that looks at the reliability of a common research tool to study RAS cancer mutations.

RAS mutations are implicated in several cancers, including lung, colorectal and pancreatic ductal carcinoma. The three RAS genes are the most frequently mutated oncogenes in , implicated in more than a quarter of all human cancers.

In pediatric cancers, mutations that activate the RAS pathway are frequently found in embryonal rhabdomyosarcoma (35 percent of tumors) and recurrent neuroblastoma (60 percent).

The Science Signaling article says that although there is intense interest in studying the development of anti-cancer strategies targeting RAS proteins, the field is held back by poor reliability of anti-RAS to recognize the members of the RAS family of proteins.

These antibodies are a critical research tool, but lack of reliability limits useful—and replicable—study results, the authors noted.

Angelina V. Vaseva, Ph.D., and Peter J. Houghton, Ph.D., director of the Greehey Institute, are the co-authors from UT Health San Antonio. Dr. Vaseva is a visiting scientist from the laboratory of Dr. Channing Der, the senior author on the study performed at the University of North Carolina at Chapel Hill, and done in collaboration with the National Cancer Institute RAS Initiative. Dr. Vaseva conducts research in the Houghton laboratory related to therapeutics of RAS-mutant childhood cancers.

The team from multiple institutions evaluated 22 commercially available anti-RAS antibodies for their capability to recognize RAS subtypes and mutated RAS.

The collaborators identified antibodies that selectively recognize each of the four human RAS proteins in human cancer cells.

This capability is only in Western blot assays, one of the most commonly used research analyses, and not in other research analyses used by laboratories worldwide.

Explore further: Editing genes one by one throughout colorectal cancer cell genome uncovers new drug target

More information: Andrew M. Waters et al. Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies, Science Signaling (2017). DOI: 10.1126/scisignal.aao3332

Related Stories

Editing genes one by one throughout colorectal cancer cell genome uncovers new drug target

September 27, 2017
Cancers driven by mutations in the KRAS gene are among the most deadly. For decades, researchers have tried unsuccessfully to directly target mutant KRAS proteins as a means to treat tumors. Instead of targeting mutant KRAS ...

Silencing cancer cell communication may reduce the growth of tumors

January 30, 2017
In several types of cancer, elevated expression of the chemokine receptor CCR4 in tumors is associated with poor patient outcomes. Communication through CCR4 may be one mechanism that cancer cells use to create a pro-tumor ...

New statistical analysis reveals thousands of rare mutations linked with cancer

April 20, 2017
Scientists have identified thousands of previously ignored genetic mutations that, although rare, likely contribute to cancer growth. The findings, which could help pave the way to new treatments, are published in PLOS Computational ...

Researchers home in on mutation profiles of clear cell endometrial cancer

May 9, 2017
In the largest genomics study of clear cell endometrial cancer (CCEC) tumors to date, National Human Genome Research Institute (NHGRI) researchers and their collaborators have identified mutations in the TAF1 gene. They've ...

New role for an old protein: Cancer causer

September 3, 2015
A protein known to play a role in transporting the molecular contents of normal cells into and out of various intracellular compartments can also turn such cells cancerous by stimulating a key growth-control pathway.

Study sheds light on dark side of tumor suppressor gene, p53

April 3, 2017
The gene p53 is the most commonly mutated gene in cancer - it is p53's job to monitor cells for DNA damage and to mark damaged cells for destruction and so cancer cells with mutated DNA must disable p53 before it disables ...

Recommended for you

BPA can induce multigenerational effects on ability to communicate

June 18, 2018
Past studies have shown that biparental care of offspring can be affected negatively when females and males are exposed to bisphenol A (BPA); however, previous studies have not characterized how long-term effects of BPA exposure ...

New compound shown to be as effective as FDA-approved drugs against life-threatening infections

June 15, 2018
Purdue University researchers have identified  a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections ...

Foods combining fats and carbohydrates more rewarding than foods with just fats or carbs

June 14, 2018
Researchers show that the reward center of the brain values foods high in both fat and carbohydrates—i.e., many processed foods—more than foods containing only fat or only carbs. A study of 206 adults, to appear June ...

3-D imaging and computer modeling capture breast duct development

June 14, 2018
Working with hundreds of time-lapse videos of mouse tissue, a team of biologists joined up with civil engineers to create what is believed to be the first 3-D computer model to show precisely how the tiny tubes that funnel ...

Beating cancer at its own game with a Trojan horse telomerase

June 13, 2018
Telomerase is a reverse transcriptase that uses an RNA template to synthesize telomeres. These repeat sequences bind special proteins that fold the ends of chromosomes back onto themselves to create a stable cap. When this ...

Turning the tables on the cholera pathogen

June 13, 2018
Recent cholera outbreaks in regions that are ravaged by war, struck by natural disasters, or simply lack basic sanitation, such as Yemen or Haiti, are making the development of new and more effective interventions a near-term ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.